Viral load reduction of Covid-19 patients
Taking SaliraVira® significantly reduces the viral load of Covid-19 patients. For comparison, the expected rates of viral load reduction of the “treatment” and “control” groups are shown in Figure 1. On the 4th day of treatment, the reduction in viral load was 27% and 10% for patients taking SaliraVira® and patients taking the routine hospital drugs, respectively. On the 8th day of treatment, the reduction of viral load in “treatment and “control” groups were 60% and 40%, respectively. Consequently, taking SaliraVira® reduces the viral load by 50% more.